<p>Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells</p>

Abstract

Background: This study demonstrated an innovative formulation including the polyprenol (GBP) lipid and vitamin E-TPGS hybrid nanoparticles (NPs) which was aimed to control the transfer of betulinic acid (BA) and low-substituted hydroxyl fullerenol (C 60 (OH) n). Additionally, it developed BA-C 60 (OH)n-GBP-TPGS-NPs delivery system and researched the anti-hepatocellular carcinoma (HCC) effects. Materials and Methods: The NPs were prepared by nanoprecipitation with ultrasonicassisted emulsification (UAE) method. It was characterized by scanning electronic microscopy (SEM), transmission electron microscopy (TEM), FTIR spectrum, size distribution and zeta potential. Physical and chemical properties were evaluated through measurement of drug release, stability studies, drug loading efficiency (DE) and encapsulation efficiency (EE). Biological activities were evaluated through measurement of MTT assay, lactate dehydrogenase leakage assay (LDH), cell proliferation assays, cell apoptosis analysis, comet assay, wound healing assay, cell invasion and Western blot analysis. Results and Conclusions: The NPs exhibited clear distribution characteristics, improved solubility and stability. BA and C 60 (OH) n for the NPs displayed a biphasic release pattern with sustained drug release properties. The mixture of C 60 (OH) n with different hydroxyl groups may have a certain effect on the stability of the NPs system itself. The NPs could effectively inhibit MHCC97H cell proliferation, migration and invasion in vitro. Combined use of C 60 (OH) n and BA in GBP lipids may improve the inhibit effect of C 60 (OH) n or BA against HCC cells and reduce cytotoxicity and genotoxicity of C 60 (OH) n for normal cells. We concluded that one of the important mechanisms of BA-C 60 (OH) n-GBP-TPGS-NPs inhibiting MHCC97H cells is achieved by up-regulating the expression of Caspase-3, Caspase-8 and Caspase-9.

Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance

“…A variety of P-gp inhibitors such as Pluronic, Verapamil, and TPGS have been discovered (Gottesman et al., 2002 ; Negi et al., 2019 ; Xu et al., 2020 ). Among them, D-α-tocopherol acid polyethylene glycolsuccinate (TPGS), an amphiphilic structure, can self-assemble to form nanoparticles and improve the permeability to cancer cells, making it an ideal nanocarrier (Wang et al., 2016 ; Popova et al., 2019 ; Tao et al., 2020 ).…”

Inhibition of SREBP-1 Activation by a Novel Small-Molecule Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Tissue to Radiofrequency Ablation

“…For these inhibitors, the main research report is to inhibit the activity of SREBP-1 as a tool in metabolism-related research. Betulin can exert anti-tumor activity in HCC (78)(79)(80). Pseudoprotodioscin and Fatostatin have been less studied in HCC, but it has also been clearly reported in other tumor types (81)(82)(83)(84).…”

MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2

“…Huh7, HCCLM3 and MHCC97H cells were from Shanghai Zhong Qiao Xin Zhou Biotechnology Co.,Ltd. [ 24 , 25 ]. Cells were cultured in DMEM (Invitrogen) in a 37 °C incubator with 5% CO 2 , supplied with 10% fetal bovine serum (Gibco) and 1% antibiotics (Corning).…”